The research is in its early stages but offers “encouraging” evidence of a potential treatment for Alzheimer’s ...

Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.

On July 2, the U.S. Food and Drug Administration (FDA) approved a new drug for treating Alzheimer’s disease. Donanemab, or Kisunla, is the third drug approved to target one of the causes of ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according to new research. Scientists have found that a byproduct of amyloid-beta ...

Prof. Liu Cong from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, ...

An estimated 50 million people worldwide have dementia, with Alzheimer's disease—accounting for more than 70%—being the representative neurodegenerative brain disorder. A Korean research team has, for ...

bacteriovorus is a predatory bacterium that preys on Gram-negative bacteria. B. bacteriovorus invades the prey-cell periplasm – the space between the inner and outer membrane – leaches host nutrients ...

Simply having higher amounts of amyloid protein in the brain is not necessarily a sign of Alzheimer’s disease, the results of a new study suggest. In fact, some forms of this protein may only signal ...

An international team led by researchers at the University of Toronto has developed an efficient and robust system, using the C. elegans nematode, to screen for compounds that can stop the growth of ...